Indofarma Tbk Stock Cash Per Share
INAF Stock | IDR 130.00 2.00 1.52% |
Indofarma Tbk fundamentals help investors to digest information that contributes to Indofarma Tbk's financial success or failures. It also enables traders to predict the movement of Indofarma Stock. The fundamental analysis module provides a way to measure Indofarma Tbk's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Indofarma Tbk stock.
Indofarma |
Indofarma Tbk Company Cash Per Share Analysis
Indofarma Tbk's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Competition |
In accordance with the recently published financial statements, Indofarma Tbk has a Cash Per Share of 0.0 times. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Indonesia stocks average (which is currently at 0.0).
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
All Next | Launch Module |
Indofarma Fundamentals
Return On Equity | -0.59 | |||
Return On Asset | -0.0451 | |||
Profit Margin | (0.1) % | |||
Operating Margin | (0.06) % | |||
Current Valuation | 3.17 T | |||
Shares Outstanding | 3.1 B | |||
Shares Owned By Insiders | 88.00 % | |||
Price To Book | 8.91 X | |||
Price To Sales | 1.25 X | |||
Revenue | 2.9 T | |||
Gross Profit | 442.87 B | |||
EBITDA | 70.22 B | |||
Net Income | (37.58 B) | |||
Total Debt | 397.52 B | |||
Book Value Per Share | 104.92 X | |||
Cash Flow From Operations | 92.9 B | |||
Earnings Per Share | (29.18) X | |||
Number Of Employees | 1.18 K | |||
Beta | -0.22 | |||
Market Capitalization | 2.59 T | |||
Total Asset | 2.01 T | |||
Z Score | 4.6 | |||
Net Asset | 2.01 T |
About Indofarma Tbk Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Indofarma Tbk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Indofarma Tbk using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Indofarma Tbk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indofarma Tbk. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Indofarma Stock analysis
When running Indofarma Tbk's price analysis, check to measure Indofarma Tbk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indofarma Tbk is operating at the current time. Most of Indofarma Tbk's value examination focuses on studying past and present price action to predict the probability of Indofarma Tbk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indofarma Tbk's price. Additionally, you may evaluate how the addition of Indofarma Tbk to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |